Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 1
1993 1
1996 2
1998 2
1999 1
2000 1
2002 1
2003 1
2004 3
2005 3
2006 3
2007 2
2008 2
2009 3
2010 2
2011 5
2012 8
2013 9
2014 7
2015 9
2016 6
2017 8
2018 7
2019 7
2020 10
2021 6
2022 7
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Metastatic uveal melanoma: The final frontier.
Rantala ES, Hernberg MM, Piperno-Neumann S, Grossniklaus HE, Kivelä TT. Rantala ES, et al. Prog Retin Eye Res. 2022 Sep;90:101041. doi: 10.1016/j.preteyeres.2022.101041. Epub 2022 Jan 6. Prog Retin Eye Res. 2022. PMID: 34999237 Free article. Review.
The final frontier in conquering uveal melanoma lies in solving these issues to cure metastatic disease. Most studies on metastatic uveal melanoma are small, uncontrolled, retrospective, and do not report staging. ...Promoting dormancy of micrometastases, har …
The final frontier in conquering uveal melanoma lies in solving these issues to cure metastatic disease. Most studies on metastatic …
Metastatic uveal melanoma.
Singh AD, Borden EC. Singh AD, et al. Ophthalmol Clin North Am. 2005 Mar;18(1):143-50, ix. doi: 10.1016/j.ohc.2004.07.003. Ophthalmol Clin North Am. 2005. PMID: 15763199 Review.
Despite achieving great accuracy in correctly diagnosing uveal melanoma in the United States, mortality owing to this tumor has remained unchanged over a period of 25 years from 1973 to 1997. In general, the survival with metastatic uveal melanoma is poor, wi …
Despite achieving great accuracy in correctly diagnosing uveal melanoma in the United States, mortality owing to this tumor has remained unc …
Metastatic uveal melanoma.
Kivelä T, Eskelin S, Kujala E. Kivelä T, et al. Int Ophthalmol Clin. 2006 Winter;46(1):133-49. doi: 10.1097/01.iio.0000195861.71558.13. Int Ophthalmol Clin. 2006. PMID: 16365560 Review. No abstract available.
Conditional Survival in Uveal Melanoma.
Zabor EC, Radivoyevitch T, Singh AD, Kilic E, de Klein JEMM, Kalirai H, Coupland SE. Zabor EC, et al. Ophthalmol Retina. 2021 Jun;5(6):536-542. doi: 10.1016/j.oret.2020.09.015. Epub 2020 Sep 23. Ophthalmol Retina. 2021. PMID: 32979556
During follow-up, 3883 patients died of any cause, and of these, 2131 deaths were the result of metastatic uveal melanoma. The nonconditional 5-year MFS was 80%. After surviving 1, 2, 3, or 4 years after diagnosis, the 5-year cMFS estimates increased to 82%, …
During follow-up, 3883 patients died of any cause, and of these, 2131 deaths were the result of metastatic uveal melanoma …
Epidemiology and management of uveal melanoma.
Yonekawa Y, Kim IK. Yonekawa Y, et al. Hematol Oncol Clin North Am. 2012 Dec;26(6):1169-84. doi: 10.1016/j.hoc.2012.08.004. Hematol Oncol Clin North Am. 2012. PMID: 23116575 Review.
Historically, enucleation was the definitive treatment of uveal melanoma, but brachytherapy and proton beam irradiation are now the most commonly used treatment methods. However, there are still no effective therapies against metastatic uveal melanoma, which …
Historically, enucleation was the definitive treatment of uveal melanoma, but brachytherapy and proton beam irradiation are now the most com …
Prognostic and predictive biomarkers in melanoma.
Maher NG, Vergara IA, Long GV, Scolyer RA. Maher NG, et al. Pathology. 2024 Mar;56(2):259-273. doi: 10.1016/j.pathol.2023.11.004. Epub 2023 Dec 20. Pathology. 2024. PMID: 38245478 Review.
Biomarkers incorporated into clinical practice guidelines include BRAF V600 mutations for the use of targeted therapies in metastatic cutaneous melanoma, and the HLA-A02:01 allele for the use of a bispecific fusion protein in metastatic uveal melanoma. Severa …
Biomarkers incorporated into clinical practice guidelines include BRAF V600 mutations for the use of targeted therapies in metastatic cutane …
Therapeutic options in metastatic uveal melanoma.
Mariani P, Servois V, Piperno-Neumann S. Mariani P, et al. Dev Ophthalmol. 2012;49:166-181. doi: 10.1159/000328333. Epub 2011 Oct 21. Dev Ophthalmol. 2012. PMID: 22042020 Review.
Systemic treatments for metastatic uveal melanoma patients give poor results. R0 resection of liver metastases showed a real benefit in survival in a very highly selected population. ...
Systemic treatments for metastatic uveal melanoma patients give poor results. R0 resection of liver metastases showed a …
Tumor lysis syndrome induced by tebentafusp.
Ruf T, Leonhardt A, Anz D, Kunz WG, Röhrle N, Foerster P, Tomsitz D, French LE, Seegräber M, Heinzerling L. Ruf T, et al. Immunotherapy. 2023 Nov;15(16):1363-1368. doi: 10.2217/imt-2023-0093. Epub 2023 Sep 4. Immunotherapy. 2023. PMID: 37661909
Tebentafusp, a bispecific T-cell receptor fusion protein directed against gp100 and CD3, can improve survival in patients with metastatic uveal melanoma and was recently approved for the treatment of HLA-A*02:01-positive uveal melanoma patients. ...
Tebentafusp, a bispecific T-cell receptor fusion protein directed against gp100 and CD3, can improve survival in patients with metastatic …
Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study.
Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Tacar SY, et al. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744. Melanoma Res. 2021. PMID: 34039945
Systemic treatment options with proven efficacy for the treatment of metastatic uveal melanoma are limited. In this study, we aimed to evaluate the efficacy of nivolumab in metastatic uveal melanoma patients. In our multi-center study, th …
Systemic treatment options with proven efficacy for the treatment of metastatic uveal melanoma are limited. In this stu …
Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline.
Weis E, Surgeoner B, Salopek TG, Cheng T, Hyrcza M, Kostaras X, Larocque M, McKinnon G, McWhae J, Menon G, Monzon J, Murtha AD, Walker J, Temple-Oberle C. Weis E, et al. Curr Oncol. 2023 Dec 20;31(1):24-41. doi: 10.3390/curroncol31010002. Curr Oncol. 2023. PMID: 38275828 Free PMC article. Review.
RESULTS: New and modified recommendations address provider training requirements, diagnostic imaging for the detection of metastases, neo-adjuvant pre-enucleation radiotherapy, intravitreal anti-vascular endothelial growth factor agents for radiation retinopathy, genetic prognost …
RESULTS: New and modified recommendations address provider training requirements, diagnostic imaging for the detection of metastases, neo-ad …
120 results